Stock AVBP ARRIVENT BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. ArriVent BioPharma, Inc.

Equities

AVBP

US04272N1028

Market Closed - Nasdaq
Other stock markets
 21:00:00 28/06/2024 BST 		5-day change 1st Jan Change
18.55 USD +6.61% Intraday chart for ArriVent BioPharma, Inc. +3.06% -.--%
06-24 ArriVent BioPharma, Inc.(NasdaqGM:AVBP) added to S&P Global BMI Index CI
06-05 ArriVent, Alphamab Unit to Collaborate on Antibody Drug Conjugates For Cancer Treatment MT

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
HC Wainwright Initiates ArriVent BioPharma With Buy Rating, $25 Price Target
MT
LifeSci Capital Starts ArriVent BioPharma With Outperform Rating, $33 Price Target
MT
Citigroup Starts ArriVent BioPharma With Buy Rating, $30 Price Target
MT
Jefferies Starts ArriVent BioPharma With Buy Rating, $35 Price Target
MT
Goldman Sachs Initiates ArriVent BioPharma With Buy Rating, Price Target is $27
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVBP Stock
  4. News ArriVent BioPharma, Inc.
  5. Analyst Reco.